Senior insider sale
Chief Business Officer at ETON PHARMACEUTICALS, INC. — senior position signals high conviction
$127.4K
7.54K shares
What this filing means
KREMPA DAVID plans to sell 7.54K shares of ETON PHARMACEUTICALS, INC. valued at approximately $127.4K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 12/12/2025ACC: 0001974078-25-000476
Officer· Chief Business Officer
Since Mar 2023
7.54K
Shares to sell
$127.4K
Approx. market value
7.54K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months2
Grant
Grant
12/11/2025
5.30KGrant
Grant
10/2/2024
2.25KTotal acquired7.54K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
12/11/2025 | Grant Grant | 5.30K | — |
10/2/2024 | Grant Grant | 2.25K | — |
| Total | 7.54K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
7.54K
Market value
$127.4K
12/12/2025
Total
Units
7.54K
Value
$127.4K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
12/12/2025 | 7.54K | $127.4K | NASDAQ | Planned |
| Total | 7.54K | $127.4K | ||